The coronavirus pandemic has dominated the headlines and our daily lives for over a year. Medical News Today has covered this fast-moving, complex story with live updates about the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask.
However, this has not stopped us from publishing hundreds of fascinating stories on a myriad of other topics.
We begin this weeks Recovery Room with new findings of research into Parkinsons disease that may also have wider implications for the treatment of other neurodegenerative diseases and cancer.
Next comes a detailed exploration of the role that carbohydrates play in the development of diabetes. Its a complex picture, and a low carb diet may not be the panacea that some claim it to be.
We also have two reports about the influence of artificial intelligence (AI) on medical research, as well as articles covering breakthroughs in HIV prevention, sickle cell disease reversal, and heart tissue regeneration.
Finally, we look at research confirming that a steady income is good for self-confidence but may have a minimal effect on feelings about other people.
We highlight this research below, along with several other recent stories that you may have missed amid all the COVID-19 fervor.
We begin with the most-read article of the past week, with more than 124,000 page views: our report on new insights into a biochemical pathway that drives Parkinsons disease. The discovery may help scientists develop treatments for this disease, as well as type 2 diabetes and cancer.
Parkin is a protein that plays a key role in maintaining cellular energy by removing damaged mitochondria, a process known as mitophagy. The new research indicates that the biochemical pathway that activates Parkin is shorter than previously thought, which helps explain how Parkin triggers mitophagy within minutes of cellular distress occurring.
Type 2 diabetes, cancer, and some neurodegenerative diseases stem from metabolic dysregulation in damaged mitochondria, so the Parkin pathway is likely to have a role in their progression, too.
Click below to learn more about how drugs developed to treat diabetes may also be used to treat Parkinsons, or click here to visit our new Parkinsons disease resource page.
Learn more here.
Our new article exploring the role that carbohydrates play in diabetes was also very popular, with over 117,000 page views so far this week.
First, our editors looked at the relationship between carb consumption, insulin, and blood sugar. They also explored how many carbs a person with diabetes should consume, good carbs, foods to include in the diet and foods to avoid, and the effects of specific diets, including a low carb diet.
The takeaway is that not all carbs are bad for a person with diabetes, but the focus should be on healthy, whole foods rather than processed foods and those high in refined sugars.
Learn more here.
Good nutrition is important at every stage of life. This week, we published a new article on the critical role of nutrition in a childs brain development, especially in the first 3 years.
Our editors first list a variety of healthy brain foods. They then share ideas for breakfasts that may help a child stay focused at school and snacks for children to try while studying. Click the link below to see the variety of foods and nutrients that should be part of every childs diet.
Learn more here.
A reliable HIV vaccine has been difficult to develop because there are so many strains of the virus, around 50 million, according to one researcher involved in a new phase 1 clinical trial.
The new course of vaccines is designed to activatebroadly neutralizing antibodies (bnAbs) that target a wide variety of HIV strains. Only one very rare type of immune cell is able to produce bnAbs, and the vaccine activated these naive B cells in 97% of participants who received it, according to the researchers.
This novel technique could also be used to make vaccines for other diseases that have proven challenging for vaccine developers, including malaria, influenza, and hepatitis C.
Learn more here.
Two of this weeks articles highlighted how AI is being deployed to aid medical research.
First, we described ways that researchers are using powerful learning algorithms to model and predict how proteins behave in human cells. Existing AI technology used to process natural language was adapted to see if it could also predict protein language and expression.
The researchers made the technique available on a new web application, linked to in our article, that allows scientists to submit a protein sequence and view its predicted behavior.
Learn more here.
We also reported on how AI is being used to analyse the brain scans of thousands of people with multiple sclerosis (MS) in an effort to learn more about the disease.
The AI program, called SuStaIn, performed an unsupervised analysis of the brain scans and detected patterns that might otherwise have been missed. As a result, three new subtypes of the disease were identified, each presenting as different types of abnormalities in the brain.
These subtypes could be used to predict a persons response to different treatments. If this finding is supported by more clinical research, it could help ensure that the correct therapy is given at the correct time.
Learn more here.
This week, we reported on a new study that concludes that a drug that appears to reverse sickle cell disease in mice is safe for humans. The drug candidate, called FTX-6058, restored the ability to produce fetal hemoglobin.
Around 1 in 365 Black people in the U.S. are born with sickle cell disease, which is relatively rare in white people. Currently, the only cure is a stem cell or bone marrow transplant, but these are very risky. FTX-6058 will now be used in a phase 2 clinical trial that includes people with sickle cell disease, for the first time, by the end of this year.
Learn more here.
Unlike humans, adult zebra fish regenerate their hearts and other organs after injury. Until recently, the way that they do this has been unclear, but researchers are now looking more closely at the role that a protein called KLF1 plays in this remarkable ability.
Inhibiting the gene for KLF1 severely limited the ability of zebra fish to regenerate heart tissue. Investigating the role of KLF1 in human hearts will require much more work, but if the protein can help regenerate heart tissue after an injury in humans, it could be a game-changer in the treatment of heart disease.
Learn more here.
April is National Autism Awareness Month, and last weeks Recovery Room featured the experience of a parent who established a school following the diagnosis of her sons autism.
This week, MNT reported on a new approach to assessing autism spectrum disorder that focuses more on proficiency and growth than deficits in a childs development. Changing the narrative in this way could help develop a more constructive and holistic way to understand each childs unique requirements and help with the selection of therapies and interventions.
This approach is also better able to account for factors such as household income and other elements of social context, compared with measuring a childs progress against a rigid set of outcomes.
Learn more here.
Finally, this week, we reported on what claims to be the first study into the emotional benefits of living with a secure income. This large study tracked the emotional responses of 1.6 million people in 162 countries.
Its key findings are that people with a steady income are more likely to feel confident and proud of themselves and that these feelings can persist for decades. However, making more money did not appear to strengthen positive feelings about others, and nor did it affect feelings such as anger.
According to this research, earnings are only linked to some inward-facing emotions, so a societys affluence may not have as strong an influence on community harmony as policymakers might expect.
Learn more here.
We hope that this weeks Recovery Room has provided a taste of the stories that we cover atMNT. We will be back with a new selection next week.
We publish hundreds of new stories and features every month. Here are some upcoming articles that may pique our readers interests:
Read the original post:
The Recovery Room: News beyond the pandemic April 16 - Medical News Today
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
- Sight Care Reviews - Overpriced or Worth the Hype? SightCare Pills ... - Journal of the San Juan Islands - November 9th, 2023
- 6 Amazing Health Benefits Of Giloy (Tinospora cordifolia) - WION - November 9th, 2023
Recent Comments